V-FLOW 21

General Data

supplementary funding
Reg Number
516485901
Sector
Medical Devices
Established
2021
No. of Employees
5
Stage
R&D
Additional Funding
1

Description

The next generation of vascular stents with a unique delivery system

Technology

VivaStent is a device for treatment of cerebral venous insufficiency.

Targeted Customers

Neurologists, Hospitals. Healthcare companies, Clinics.

Management personnel

Yossi Mazel - CEO
Boaz Harari - CTO

Contact information

Name
Yossi Mazel
Phone
0545740045
Website
https://vflow21.com/
Country
Israel

Tags

BrainTechHealthtechLife SciencesMedical DevicesMedTechNeurologyTreatment

Classified Technologies

Medical Engineering
Medical Devices

Winning details

Route name
Winning year

The Expedited Program
The Expedited Program
2023
Startup Fund
Startup Fund
2025